Use of the Xpert Breast Cancer STRAT4 for Biomarker Evaluation in Tissue Processed in a Developing Country.

Marcellin MugabeKenneth E HoDeo RuhangazaDan MilnerBelson RugwizangongaVictor C ChuNatalie C WuAnnaliza RizoJodi M WeidlerWendy WongMichael BatesJane E Brock

Published in: American journal of clinical pathology (2021)

The STRAT4 assay is an alternative for providing quality-controlled breast cancer biomarker data in laboratories unable to provide quality and/or cost-efficient IHC services.

Keyphrases

healthcare
primary care
quality improvement
high throughput
electronic health record
big data
machine learning
young adults
artificial intelligence
deep learning
single cell
affordable care act